Practice Areas

Print PDF

Purdue's Sleep Aid Patents Are Obvious, Judge Rules

March 30, 2015

A New Jersey federal judge on Friday found that Purdue Pharmaceutical Products LP’s three patents for sleep aid Intermezzo are invalid for obviousness, granting a win to Actavis Elizabeth LLC, Novel Laboratories Inc. and others whom Purdue sued over plans to market their own generic versions of the drug.

Dr. Reddy’s was represented by members of Cantor Colburn’s Pharmaceutical Litigation Practice Group.

Click here to read the press release.

Law360 logo

View Document(s):